Xenon Pharmaceuticals Inc (XENE)
40.10
+0.60
(+1.52%)
USD |
NASDAQ |
Apr 25, 16:00
40.12
+0.02
(+0.05%)
Pre-Market: 20:00
Xenon Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2022 | 13.17M |
| June 30, 2022 | 21.16M |
| March 31, 2022 | 22.84M |
| December 31, 2021 | 18.44M |
| September 30, 2021 | 19.85M |
| June 30, 2021 | 18.28M |
| March 31, 2021 | 29.45M |
| December 31, 2020 | 32.17M |
| September 30, 2020 | 30.34M |
| June 30, 2020 | 27.29M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.311M |
| September 30, 2017 | 0.671M |
| June 30, 2017 | 0.82M |
| March 31, 2017 | 1.218M |
| December 31, 2016 | 1.803M |
| September 30, 2016 | 4.654M |
| June 30, 2016 | 8.535M |
| March 31, 2016 | 12.17M |
| December 31, 2015 | 15.58M |
| September 30, 2015 | 17.23M |
| June 30, 2015 | 26.13M |
| March 31, 2015 | 27.38M |
| December 31, 2014 | 28.37M |
| September 30, 2014 | 29.08M |
| June 30, 2014 | 26.67M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
13.17M
Minimum
Sep 2022
32.17M
Maximum
Dec 2020
23.30M
Average
22.00M
Median
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.386M |
| ESSA Pharma Inc | -- |